Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421233A Compound pain-stopping and inflammation-diminishing anticarcinogen capsule
06/04/2003CN1421229A Chinese medicine for treating hepatocirrhosis, hepatitis and liver cancer
06/04/2003CN1421224A Recipe of Chinese medicine for treating breast cancer
06/04/2003CN1421222A Chinese medicine composition for treating tumor
06/04/2003CN1421219A Chinese medicine for treating women's ovary cancer and uterine myoma
06/04/2003CN1421203A New application of berbamine as intracorporeal antitumor drug
06/04/2003CN1421201A Taxane injecta preparation
06/04/2003CN1110559C Gene for regulating aureobasidin sensitivity
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110477C 1,25-dihydroxy-16,22,23-trisdehydro-chdecalciferol derivatives
06/04/2003CN1110322C Monoclonal antibody Fab'-pingyangmycin conjugate and its anticancer action
06/04/2003CN1110319C Antineoplastic medicine and health-care food containing earthworm plasmin
06/04/2003CN1110312C Medicine with wild cottonrose hibiscus
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
06/03/2003US6573293 Anticancer agents
06/03/2003US6573292 Treatment of Chronic Lymphocytic Leukemia and B- cell and T-cell lymphomas are provided. These methods comprise administering to a patient in need of treatment an effective amount of certain indole and carbazole compounds, such as
06/03/2003US6573290 DFMO and celecoxib in combination for cancer chemoprevention and therapy
06/03/2003US6573288 Compounds are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of
06/03/2003US6573273 Urea substituted imidazoquinolines
06/03/2003US6573271 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573265 Preventing or treating diseases caused by free radicals of the cellular oxygen metabolism, stimulating nerve cell growth, antagonizing glutamate receptors and/or stimulating the growth notably of glutamergic nerve cells; anticarcinogenic agents;
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573255 Vitamin D analogues
06/03/2003US6573253 Methods for the administration of amifostine and related compounds
06/03/2003US6573248 Monocyclic L-nucleosides, analogs and uses thereof
06/03/2003US6573246 Modified ether glyceroglycolipids
06/03/2003US6573245 Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6573074 Methods for ansamitocin production
06/03/2003US6572884 Parenteral Cisplatin emulsion
06/03/2003US6572874 Vaginal delivery of bisphosphonates
06/03/2003US6572857 Psoriasis; humanized sub clone of IOR T1A produced by the hybridoma deposited with ECACC, CAMR under accession number 96112640, having heavy and light chains with humanized variable regions.
06/03/2003US6572856 Classic complement pathway, C3 convertase
06/03/2003US6572854 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
06/03/2003US6572852 Genetic engineering
06/03/2003US6572839 Sensitizer for tumor treatment
06/03/2003CA2332652C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
06/03/2003CA2094275C Methods and compositions for the treatment of cell proliferation disorders
05/2003
05/30/2003WO2003044524A2 Methods and means for influencing intracellular communication and intracellular organelle transport
05/30/2003WO2003044209A1 Novel tetronic acid derivative
05/30/2003WO2003044208A1 Novel tetronic acid dervative
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044183A1 Interleukin-2 gene transferred lymphokine activated killer cells
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044036A1 Tumor specific monoclonal antibodies
05/30/2003WO2003044031A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003044005A1 Cruentaren a and b as pharmaceuticals and agrochemicals
05/30/2003WO2003043998A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043983A1 Piperazine derivatives destabilising androgen receptors
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043966A2 Clusianon isomers and use thereof
05/30/2003WO2003043662A1 Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin
05/30/2003WO2003043658A1 Anti-proliferative composition
05/30/2003WO2003043657A1 Topical delivery of codrugs
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043632A2 Use of bisindolmaleimide and gemcitabine for the treatment of cancer
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003043630A1 Solid pharmaceutical composition comprising 4-cyano-trifluoro-3-(4-fluorophenyl sulphonyl)-2-hydroxy-2-methylpropiono- m toluidide, pvp, an anti-oestrogen and/or an aromatase inhibitor
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043622A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
05/30/2003WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
05/30/2003WO2003043606A1 Pharmaceutical formulation comprising bicalutamide
05/30/2003WO2003043604A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003043581A2 Composition and method for modulating bar/fxr receptor activity
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003028697A3 Liposome loading with metal ions
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003026691A3 Use of hmgb1 for the activation of dendritic cells
05/30/2003WO2003025176A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003006055A3 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
05/30/2003WO2003005952A3 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002098891A3 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
05/30/2003WO2002097119A3 Use of the indication of the expression of splice variants of gene 21 for the diagnosis and treatment of tumour diseases
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002089829A3 Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer
05/30/2003WO2002085848A8 Synthesis of pancratistatin prodrugs
05/30/2003WO2002078718A3 Compositions, methods and apparatuses for singlet oxygen delivery
05/30/2003WO2002078698A3 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
1 ... 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 ... 2211